MedCon 2025 convened this week at the Hyatt Regency Columbus in Columbus, Ohio, welcoming 240 attendees from nine countries and four continents for three days of purpose-driven discussions that harmonize different perspectives to inspire collaboration, lead innovation, and make a difference in patient care. The event was hosted by the AFDO/RAPS Healthcare Products Collaborative.
“MedCon is the perfect size for collaboration, where you can share experiences and talk to so many different people,” said Kim Belsky, Strategic Facilitator MedCon-Combination Products Summit, AFDO/RAPS Healthcare Products Collaborative. “This is where you get the inspiration that tells you that you are on the right track. I saw so many people taking notes and getting those points of inspiration.”
The MedCon Strategic Committee curated the educational program which consisted of 59 speakers and moderators across 21 sessions, including FDA expert presenters. Key content themes centered on updates from FDA, patient experience stories, medical device inspections, MDR/IVDR, EUDAMED, quality system activities, supply chain resiliency, cybersecurity, due diligence, regulatory resilience, QMSR, 510(K) review challenges, risk management,
clinical expectations, and investigator insights. In addition, attendees participated in an interactive Solutions Exchange case study which explored the culture of quality.
The event also featured a preconference workshop on Tuesday, April 22, entitled “The Device Design Change Life Cycle Experience,” featuring former FDA staffers and expert presenters from STERIS Corporation, Eliquent Life Sciences, Eli Lilly and Company, and KeborMed. This daylong workshop helped attendees navigate the complex pathway from initiation to implementation via interactive activities.
“We decided to attend MedCon 2025 to see how we function as part of the ecosystem,” said first-time attendee Brian Dawson, Business Development Director, AltaSim Technologies. “The patient impact story was particularly insightful. It was great to see how companies on the design side and regulatory bodies align in affecting patient outcomes.”
Since 2009, MedCon has united the healthcare products industry to work for a better tomorrow for our patients. With a distinct focus on important issues that increase speed to market and product quality through innovation, the event brings together medical device regulators and industry experts from around the world for content-rich conference sessions that include uncommon collaboration, deep dialogue, and sharing.
Sign up for information and updates on MedCon 2026 by visiting www.healthcareproducts.org/medcon.
About the AFDO/RAPS Healthcare Products Collaborative
The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS).
Continuing and expanding upon Xavier Health’s legacy, the Collaborative supports idea sharing, innovation, and action across the global healthcare products community by fostering purpose-driven discussions between regulators, industry, academia, and thought leaders about the most pressing issues facing the industry.
The Collaborative’s distinct events portfolio — which includes the MedCon Conference, AI Summit, Combination Products Summit, and PharmaLink Conference — highlights just one of the ways the partnership inspires collaboration. This unique blend of mission and values guides purpose-driven community building and innovative solutions to make a difference in patients’ lives. www.healthcareproducts.org
Media Contacts
Jason Brill
Association of Food and Drug Officials (AFDO)
jbrill@afdo.org
(216) 571-1767
Ryan Connors
Regulatory Affairs Professionals Society (RAPS)
rconnors@raps.org
(301) 770-2920, ext. 234
